In support of this hypothesis, we observed similar results in three different experimental settings: 1) mice infected with two different T. cruzi strains (Tulahuen and Y), 2) in OT-I T. cruzi- infected mice (pathogen-independent model) and 3) in the absence of infection as in IL-12+IL-18 systemically treated mice. This evidence concerns the gene IL18 and infection.